TechDogs-"Hansa Biopharma Nomination Committee formed"


Hansa Biopharma Nomination Committee formed

By PR Newswire

PR Newswire
Overall Rating

TechDogs-"Hansa Biopharma Nomination Committee formed"
LUND, Sweden
, Dec. 23, 2022 /PRNewswire/ -- Hansa Biopharma today announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on June 30, 2022 and has the following composition:

  • · Natalie Berner representing Redmile Group
  • · Jannis Kitsakis representing AP4
  • · Arne Myhrman representing Thomas Olausson

As the conveyer of the Nomination Committee, Peter Nicklin, Chairman of the Board of Directors at Hansa Biopharma will be asked to summon the first meeting in the Nomination Committee.

The function of the Nomination Committee is to prepare and submit proposals for the AGM regarding the number of board members to be elected by the general meeting, election of chairman and other board members, board fees and any remuneration for committee work, election of the chairman of the AGM, election of auditors (if applicable) and fee for the auditors, and proposals for rules for appointing the Nomination Committee.

The proposals of the Nomination Committee will be presented in the notice of the Annual General Meeting 2023 and will be published on Hansa Biopharma's website.

Shareholders wishing to submit comments or proposals to the Nomination Committee may do so via e-mail to or by letter to Hansa Biopharma, Nomination Committee, Box 785, 220 07 Lund, Sweden.

This disclosure contains information that Hansa Biopharma AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 23 December 2022 at 8am CET.


For further information, please contact:

Klaus Sindahl, Head of Investor Relations

Hansa Biopharma 

Mobile: +46 (0) 709-298 269


The following files are available for download:

20221216 HNSA - PR Nomination Committee 2022-2023 ENG

View original content:

SOURCE Hansa Biopharma AB

Head to the TechDogs homepage to find the latest tech content infused with drama and entertainment. We've got ArticlesWhite PapersCase StudiesReportsVideos and Events – the complete lot to help you Know Your World of Technology.

First published on Fri, Dec 23, 2022

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs’ members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs’ Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs’ site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.


Hansa Biopharma AB Nomination Committee Biopharmaceutical Enzyme Technology


Join The Discussion

  • Dark
  • Light